Longitudinal Study of the Relationship Between Chemoradiation Therapy for Non–Small-Cell Lung Cancer and Patient Symptoms
- 20 September 2006
- journal article
- supportive care-and-quality-of-life
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (27) , 4485-4491
Abstract
Purpose: Cancer patients undergoing aggressive therapy suffer from multiple nonspecific treatment-related symptoms. The goal of this prospective study was to establish a profile of the development of different symptoms over the time of therapy and to examine symptom-related functional interference in patients with non–small-cell lung cancer (NSCLC) undergoing concurrent chemoradiation therapy (CXRT). Patients and Methods: Patients with locally advanced unresectable (stage II-IIIB) NSCLC were recruited for the study (N = 64). The M.D. Anderson Symptom Inventory (MDASI) was used to measure multiple symptoms before and weekly for 12 weeks after the start of CXRT. Mixed-effect growth curve models were used to estimate symptom development during CXRT. Results: Approximately 63% of patients suffered from moderate to severe levels of multiple symptoms by the end of CXRT. Symptom clusters with four development patterns appeared over the time of CXRT. With some variation between patients, all symptoms had a significant impact on the level of interference (all P < .001). Fatigue, distress, and sadness were the single strongest predictors of total symptom interference (each R2 ≥ 0.49). Physical symptoms had greater impact on interference with function when they were moderate to severe, whereas affective symptoms had the largest effect on interference when they were mild to moderate. Conclusion: Longitudinal analysis identified symptom clusters that have different development patterns in NSCLC patients receiving CXRT, providing a base for more accurate symptom management and suggesting the need for further study to identify potential mechanisms that might lead to better symptom control or prevention.Keywords
This publication has 18 references indexed in Scilit:
- Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancerCancer Chemotherapy and Pharmacology, 2006
- A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancerInvestigational New Drugs, 2005
- In BriefCurrent Problems in Surgery, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002JNCI: Journal of the National Cancer Institute, 2003
- Topoisomerase I Inhibitors in the Combined Modality Therapy of Lung CancerClinical Lung Cancer, 2001
- Assessing symptom distress in cancer patientsCancer, 2000
- Cancer-related symptomsSeminars in Radiation Oncology, 2000
- The rapid assessment of fatigue severity in cancer patientsCancer, 1999
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995